DSG Press Release

Back DSG Press Release – April, 2022
DSG software used to streamline At-Home infused patient decentralized trial
Kelly Morrione, Marketing Associate

Written By
Kelly Morrione,
Marketing

eCaseLink Unified Platform Used to Streamline At-Home Infused Patient Decentralized Trial

MALVERN, Pa., April, 2022 – DSG, Inc., a global leader of eClinical software solutions and services for the life sciences industry has successfully supported a remote at-home infused patient decentralized trial for cancer patients who are unable to visit infusion centers or traditional clinical trial sites.

Understanding the urgent nature and the challenges faced by physicians looking for options to treat home-bound cancer patients, DSG worked in unison with physicians to complete a full study design in a matter of days. Both teams leveraged their combined knowledge and experience to collaborate and identify the most effective way to get the study up and running as quickly as possible. The study included home-bound cancer patients, dispersed throughout the U.S., who received daily in-home oncology treatment infusions, along with study IP through home-pumps. Patients were unable to visit an infusion center or a traditional clinical trial site. DSG collaborated with a centrally-located writing physician and leveraged Home Health nurses who visited patients to collect data, blood samples, and facilitate home pump functions.

DSG’s decentralized trial unified platform, eCaseLink, provided a seamless workflow for each stakeholder. Doctors and nurses were able to log into the platform using remote wearable devices to communicate patient status and updates. DSG’s team used an agile approach to accelerate the clinical study implementation by leveraging eCaselink's configuration efficiencies with exceptional responsiveness and flexibility. The sponsor operations team provided inputs on the study challenges and collaborated with DSG’s team in crafting optimal solutions to build the ideal system in a very short amount of time and within budget.

“We are committed to providing solutions using our innovative clinical software and resources in an effort to design effective decentralized clinical trials to support home-bound patients battling cancer,” said Tony Varano, CEO and Founder of DSG. “But at the end of the day, a successful trial is built by people through collaboration and teamwork.”

The clinical trial system, incorporating multiple modules and third-party integrations within DSG’s unified platform, was successfully rolled out to clinical sites and patients are currently being enrolled, randomized and dosed efficiently within the system.

About DSG

DSG, Inc. is a leading global eClinical provider with a unified suite of innovative technology solutions for the global clinical research community. DSG's eClinical software platform provides competitive advantage that is cost-effective and quickest to build. DSG’s award-winning eCaseLink solutions are used in thousands of clinical trials around the globe.

  • DSG Contact Information
  • 325 Technology Drive
  • Malvern, PA 19355

  • Marketing & Communications
  • Phone: 484.913.2118